Hypertension and Health-Related Quality of Life (HRQoL): Evidence from the US Hispanic Population
- 11 Downloads
Background and Objective
Little evidence exists regarding the marginal decrease in health-related quality of life (HRQoL) in relation to the presence of hypertension among a Hispanic population based on US population-based research.
This cross-sectional study used data from the 2014 to 2015 Medical Expenditure Panel Survey (MEPS). The target population was comprised of Hispanic community-dwelling residents with hypertension in the USA. The independent variable was the presence of hypertension. The dependent variable was HRQoL, which was measured using the Short Form-12 (SF-12) physical health composite scale (PCS) and mental health composite scale (MCS).
A total of 13,933 members of the Hispanic population met the study inclusion criteria, and the estimated population size was 36,440,400 Hispanics. Among them, 82.9% did not have any hypertensive condition (n = 11,466), while 17.7% had some hypertensive condition (n = 2467). SF-12 PCS scores (95% CI) were 46.62 (45.68–47.57) in the Hispanic population with hypertension and 51.62 (51.1–52.14) in the Hispanic population without hypertension. SF-12 MCS scores (95% CI) were 52.67 (52.07–53.27) in patients without hypertension and 50.35 (49.45–51.26) in the Hispanic population with hypertensive conditions.
The presence of hypertension was associated with lower HRQoL in the Hispanic population. Based on our findings, we suggest that healthcare providers should monitor a hypertensive minority population for anxiety and mood disorders and recommend psychiatric assessment and treatment if appropriate.
Compliance with Ethical Standards
Conflict of interest
Elizabeth Riley, Chanhyun Park, Sean Kim, Inho Song, and Jongwha Chang declare no conflicts of interest.
This project was supported by a UTEP School of Pharmacy Seed Grant (226811487A).
Institutional Review Board (IRB) approval was waived since MEPS is a publicly available de-identified dataset.
- 1.Hayes DK, Denny CH, Keenan NL, Croft JB, Greenlund KJ. Health-related quality of life and hypertension status, awareness, treatment, and control: National health and nutrition examination survey, 2001–2004. J Hypertens. 2008;26(4):641–7. https://doi.org/10.1097/HJH.0b013e3282f3eb50.CrossRefGoogle Scholar
- 2.Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–357.CrossRefGoogle Scholar
- 4.Whelton PK, Carey RM, Aronow WS, Casey D, Collins KJ, Himmelfarb CD, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PNCA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13–115.Google Scholar
- 5.Hypertension Among Adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/data/databriefs/db133.htm#x2013;2012. Published October 31, 2013. Accessed 29 Jan 2019.
- 6.Sánchez V, Cacari Stone L, Moffett ML, Nguyen P, Muhammad M, Bruna-Lewis S, Urias-Chauvin R. Process evaluation of a promotora de salud intervention for improving hypertension outcomes for latinos living in a rural US-mexico border region. Health Promot Pract. 2014;15(3):356–64.CrossRefGoogle Scholar
- 11.Theodorou M, Kaitelidou D, Galanis P, Middleton N, Theodorou P, Stafylas P, et al. Quality of life measurement in patients with hypertension in Cyprus. Hellenic J Cardiol. 2011;52:407–15.Google Scholar
- 14.Fox C, Golden S, Anderson C, Bray G, Burke L, de Boer I, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2015;38(9):1777–803.CrossRefGoogle Scholar
- 21.Meps.ahrq.gov [Medical Expenditure Panel Survey Background]. Agency for Healthcare Research and Quality. Available at http://meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp. Accessed 31 Jan 2019.
- 22.Cohen SB. Design strategies and innovations in the medical expenditure panel survey. Med Care. 2003;41(Suppl 7):III5–12.Google Scholar
- 29.Hajian-Tilaki K, Heidari B, Hajian-Tilaki A. Are gender differences in health-related quality of life attributable to sociodemographic characteristics and chronic disease conditions in elderly people? Int J Prev Med. 2017;8:95.Google Scholar
- 32.Burdine JN, Felix MR, Abel AL, Wiltraut CJ, Musselman YJ. The SF-12 as a population health measure: an exploratory examination of potential for application. Health Serv Res. 2000;35(4):885–904.Google Scholar